All Type of News
KFDA to set up stringent guideline on diet pills
The Korea food and Drug Administration is considering establishing a new guideline to strictly control obesity drugs, such as psychotropic drugs, which have been used to treat obesity.
Korea has banned sales of con...
Wholesalers adopt resolution over rebate plan
The Korea Pharmaceutical Wholesaler Association said on November 24 it has decided to accept a resolution to strictly abide by a revised law that punishes doctors for shady deals with drug makers.
In a recent meeti...
SK Chemicals to set out flu vaccine production plan
In a move to contain pandemic flu fears, SK Chemicals plans to construct its large-scale influenza vaccine plant in Andong of North Chungcheong Province, which will be fully backed by the government and provincial bod...
Hemophila patients call for lifting age restriction over insurance of Kogenate FS
Will hemophila patients be able to get cheaper and better drugs this year?
Now all eyes are on the Ministry for Health, Welfare and Family Affair's decision on the insurance price of Kogenate FS, a new drug for th...
Local drug makers mulls remuneration over API manufacturer
With the new DMF (drug master file) system to take effect next year, local drug manufacturers are considering paying any royalty-like money to DMF-endorsed API (active pharmaceutical ingredient) manufacturers, to get ...
Lim’s resignation sparks debate over local CEO’s authority
The sudden resignation of Hanmi Pharmaceutical President Lim Sun-min has sparked a debate in industry.
He seemingly decided to step down to take responsibilities for poor sales this year, but many say the timing is...
Cabinet endorses bill on license of healthcare providers
The government on Tuesday approved a bill allowing those suffering from mild depression, except for patients with serious mental disorder, to get a doctor or pharmacist license without restriction, stepping up efforts...
Kwandong, Salvat ink agreement over OAB medicine
Kwangdong Pharmaceutical said on November 16 that it has signed a licensing agreement with Spain based Laboratorios SALVAT, S.A. (Salvat), granting the former the rights to develop, register and market Tarafenacin in ...
Korea to crack down on bribe-taking doctors and pharmacists
When it comes to bribery in the medical field, it is mostly the companies offering the bribes that are subject to prosecution in the local pharmaceutical industry.
Starting on Nov. 28, however, those who accept ki...
Prices of 254 antihypertensive agents to be reduced from next January
The Ministry of Health and Welfare says health insurance prices of 254 antihypertensive medications, including Cozzar, will be reduced from January 2011 to January 2013.
The lowered drug prices are expected to help h...
